Fibrinogen A alpha-chain associated amyloidosis: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{SK}} ==Overview== ==Historical Perspective== ==Classification== ==Pathophysiology== ==Causes== ==Epidemiology and Demographics==..." |
|||
Line 4: | Line 4: | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
{{SK}} | {{SK}}Fibrinogen amyloidosis | ||
==Overview== | ==Overview== | ||
==Historical Perspective== | ==Historical Perspective== | ||
Fibrinogen amyloidosis was first discovered by Dr Merill Benson et al, an American physician, in 1993. | |||
==Classification== | ==Classification== |
Revision as of 19:36, 4 November 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Synonyms and keywords:Fibrinogen amyloidosis
Overview
Historical Perspective
Fibrinogen amyloidosis was first discovered by Dr Merill Benson et al, an American physician, in 1993.